Specialized disease-modifying anti-rheumatic drugs (DMARDs) developed to preserve functional joint mobility, prevent structural cartilage erosion, and sustain clinical remission in autoimmune arthropathies.
Hydroxychloroquine Sulfate Tablets (200mg, 400mg)
Methotrexate Tablets IP (2.5mg, 7.5mg, 10mg)
